Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis.
15/11/2022
/
Publications
This systematic review included 24 studies for analysis in order to compare the incidence of SMNs after proton and photon-based radiation for pediatric CNS...
Proton and carbon ion beam treatment with active raster scanning method in 147 patients with skull base chordoma at the Heidelberg Ion Beam Therapy Center-a single-center experience.
15/11/2022
/
Publications
/
Survival
This study from the Heidelberg group compared the results of 111 skull-base chordoma patients treated with carbon ion of 66 GyRBE and 36 patients treated with...
Particle beam therapy for nasopharyngeal cancer: A systematic review and meta-analysis.
15/11/2022
/
Publications
/
Survival
This is a systematic review on particle beam including proton and carbon ion therapy for primary or recurrent nasopharyngeal cancer (NPC). Twenty-six eligible...
Outcomes and Toxicities of Nonmedullary Thyroid Tumors Treated with Proton Beam Radiation Therapy.
15/11/2022
/
Publications
/
Survival
This retrospective study evaluated 22 patients with thyroid cancer treated with PBT to a total dose of 60 GyRBE adjuvantly and 70 GyRBE for gross disease. With...
Systematic Review for Deep Inspiration Breath Hold in Proton Therapy for Mediastinal Lymphoma: A PTCOG Lymphoma Subcommittee Report and Recommendations.
15/11/2022
/
Publications
/
IMPT
IMRT
Published in the Green Journal, the PTCOG lymphoma subcommittee conducted a systematic review on available dosimetric studies comparing IMPT free breathing (FB)...
High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial.
15/11/2022
/
Publications
/
IMPT
IMRT
This is a study protocol details a randomized trial taking place in Thailand with multiple centers comparing IMPT and IMRT for stage II–IVA squamous thoracic...
Proton Beam Therapy for Esophageal Cancer.
15/11/2022
/
Publications
/
Clinical Trial
A latest review examined the existing of PBT for locally advanced esophageal cancer, including dosimetric comparative studies, early clinical outcome...
Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis.
15/11/2022
/
Publications
/
Hypofractionation
This systematic review evaluated eight studies and 401 patients with early stage NSCLC treated with hypofractionated PBT to a median total dose of 63 Gy(RBE)...
Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer.
15/11/2022
/
Publications
/
IMPT
IMRT
163 consecutively treated patients with biopsy-proven, stage III NSCLC who received IMPT (n = 35, 21%) or IMRT (n = 128, 79%) were analyzed in this study...
Clinical Outcomes Following Proton and Photon Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer.
15/11/2022
/
Publications
A study by the Samsung group Korea reported the clinical outcomes of 168 patients with early stage of NSCLC treated by photon SBRT and 34 with proton SBRT...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.